Ahinkogye — Hermetica Encyclopedia
Herb · African

Ahinkogye (Euphorbia tirucalli)

Preliminary EvidenceCompound

Hermetica Superfood Encyclopedia

The Short Answer

Euphorbia tirucalli contains ferulic acid as its principal phenolic compound alongside polyphenols, flavonoids, and terpenoids that confer antioxidant and antimicrobial activity through free radical scavenging and membrane disruption mechanisms. In vitro studies demonstrate DPPH EC50 values as low as 12.15 μg/mL and antimicrobial inhibition zones of 22.81 mm against E. coli at 200 μg/mL, though no human clinical trials have confirmed these effects in vivo.

PubMed Studies
6
Validated Benefits
Synergy Pairings
At a Glance
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordAhinkogye Euphorbia tirucalli benefits
Ahinkogye close-up macro showing natural texture and detail — rich in antioxidant, antimicrobial, skin
Ahinkogye — botanical close-up

Health Benefits

**Antioxidant Activity**: Ferulic acid and polyphenols (up to 106
32 mg GAE/g in ethyl acetate fractions) scavenge reactive oxygen species, with ABTS assay values exceeding 718.99 μM trolox/g in dry plant extracts, indicating potent free radical neutralization.
**Antimicrobial Potential**
Chloroform extracts inhibit Gram-positive bacteria including Staphylococcus aureus and Bacillus subtilis (zone of inhibition 18.01 mm at 200 μg/mL) and Gram-negative E. coli (22.81 mm), relevant to traditional topical skin applications.
**Antifungal Properties**: Chloroform fractions at 0
5% and 1.0% concentrations caused 90% and 95% growth inhibition of Colletotrichum gloeosporioides respectively, suggesting utility in managing fungal skin conditions aligned with traditional Akan use.
**Cytotoxic Activity Against Cancer Cells**
Aqueous and methanol extracts at 200 μg/mL reduced cancer cell viability to approximately 25% and 7% respectively in vitro, with cytotoxicity also confirmed via Artemia salina bioassay (LC50 1.381 μg/mL for methanol extract).
**Skin Condition Management (Traditional)**
Akan communities in Ghana and traditional South African healers apply preparations of E. tirucalli topically for dermatological conditions, a practice supported circumstantially by the plant's documented antimicrobial and antioxidant chemistry.
**Anti-inflammatory Potential**
The terpenoid and flavonoid constituents, including compounds identified via GC-MS such as phytol and n-hexadecanoic acid, are structurally associated with inhibition of pro-inflammatory enzymatic pathways, though direct mechanistic studies are not yet published for this species.

Origin & History

Ahinkogye growing in Africa — natural habitat
Natural habitat

Euphorbia tirucalli is native to semi-arid tropical regions of Africa, particularly sub-Saharan Africa, with significant presence in Ghana, South Africa, Madagascar, and parts of East Africa. The plant thrives in dry, rocky soils and full sun exposure, making it highly drought-tolerant and well-suited to savanna and bushveld ecosystems. It is also widely naturalized across tropical Asia and Latin America, where it has been introduced as a hedge plant and traditional remedy.

Euphorbia tirucalli, known as Ahinkogye among the Akan people of Ghana, holds a recognized place in West African and Southern African ethnobotanical traditions, where the latex and stem preparations have been used for dermatological complaints including warts, eczema, and skin infections. In South African traditional medicine, the plant is known by various names across Zulu, Sotho, and Afrikaans-speaking communities and has been employed both topically and, with considerable caution, internally for conditions including cancer, rheumatism, and venereal disease. The milky latex of the plant is a well-known vesicant and caustic agent, a property recognized by traditional healers who typically dilute or process preparations carefully before application. The plant's widespread use as a living fence and ornamental hedge across tropical Africa, Asia, and the Americas has also contributed to its accessibility as a medicinal resource in rural communities.Traditional Medicine

Scientific Research

All published scientific evidence for Euphorbia tirucalli derives exclusively from in vitro laboratory studies; no human clinical trials, randomized controlled trials, or pharmacokinetic studies in human subjects have been published as of current literature. Available research includes microbiological inhibition assays, Artemia salina cytotoxicity bioassays, DPPH and ABTS antioxidant assays, and cancer cell viability experiments using aqueous, methanol, chloroform, ethyl acetate, and petroleum ether extracts of stems and whole plant material. Quantified outcomes include antioxidant EC50 values of 12.15–16.59 μg/mL and polyphenol concentrations of 16.65–106.32 mg GAE/g depending on extraction solvent and plant fraction. The evidence base is preclinical and cannot be extrapolated to therapeutic dosing, safety, or efficacy in humans without supporting clinical investigation.

Preparation & Dosage

Ahinkogye prepared as liquid extract — pairs with No published studies document synergistic combinations of Euphorbia tirucalli with other ingredients in human or animal models. Based on shared antioxidant mechanisms, hypothetical complementarity exists with other polyphenol-rich botanicals such as green tea extract (EGCG) or rosemary (rosmarinic acid), where combined free radical scavenging could produce additive effects
Traditional preparation
**Traditional Topical Preparation (Akan/South African)**
Fresh latex or macerated plant material applied directly to affected skin areas; exact concentration and frequency are undocumented in peer-reviewed sources.
**Laboratory Methanol Extract**
Used at 25–200 μg/mL in in vitro studies; no equivalent human supplemental dose established.
**Laboratory Chloroform Extract**
Active antimicrobial effects observed at 200 μg/mL in disk diffusion assays; no translatable human dose available.
**Ethyl Acetate Fraction**
32 mg GAE/g) and flavonoid content (450
Highest polyphenol content (106..83 μg QE/g) recorded in this solvent fraction; not commercially standardized.
**Important Note**
No standardized commercial supplement form, capsule, tincture, or extract with defined phytochemical concentration exists for this ingredient. All dosing data are derived from laboratory experiments and cannot be used as prescriptive guidance for human use.

Nutritional Profile

Euphorbia tirucalli is not consumed as a dietary food source due to the caustic and toxic nature of its latex; its nutritional profile in the classical macronutrient sense is not applicable. Phytochemically, stem extracts contain total polyphenols of 16.65–106.32 mg GAE/g depending on solvent fraction, flavonoids of 97.97–450.83 μg QE/g, with ferulic acid as the dominant identified phenolic compound by HPLC-UV analysis. GC-MS analysis identifies lipid-class constituents including 9,12-octadecadienoic acid (linoleic acid), n-hexadecanoic acid (palmitic acid), dodecanoic acid (lauric acid), tetradecanoic acid (myristic acid), and phytol (a diterpene alcohol). Alkaloids, tannins, and terpenoids are qualitatively confirmed by phytochemical screening, while saponins and anthraquinones were notably absent in analyzed extracts; bioavailability data for any constituent in human subjects is entirely absent from published literature.

How It Works

Mechanism of Action

Ferulic acid, the principal identified phenolic compound in E. tirucalli, exerts antioxidant effects by donating hydrogen atoms to neutralize free radicals and chelating transition metal ions that catalyze oxidative reactions, thereby reducing lipid peroxidation and oxidative stress. Flavonoids present in concentrations up to 450.83 μg QE/g in ethyl acetate fractions may inhibit cyclooxygenase and lipoxygenase enzymes, contributing to potential anti-inflammatory and anti-proliferative effects at the cellular level. Terpenoid constituents and fatty acid derivatives such as 9,12-octadecadienoic acid (linoleic acid) identified via GC-MS may disrupt microbial membrane integrity through intercalation into phospholipid bilayers, explaining the observed broad-spectrum antimicrobial activity. Cytotoxic activity against cancer cells is hypothesized to involve pro-apoptotic signaling related to reactive oxygen species generation at higher concentrations, though specific receptor targets and gene expression pathways have not been elucidated in published molecular studies.

Clinical Evidence

No human clinical trials have been conducted on Euphorbia tirucalli or its standardized extracts. The entirety of the clinical-adjacent evidence consists of cell culture cytotoxicity assays showing reduced cancer cell viability to 7–25% at 200 μg/mL, and microbial inhibition zone assays confirming antibacterial and antifungal activity in controlled laboratory conditions. Effect sizes from these in vitro models are promising but carry no direct transferability to human therapeutic outcomes without dose-response modeling, pharmacokinetic data, and safety studies. Confidence in any clinical benefit remains very low given the complete absence of human subject research.

Safety & Interactions

Euphorbia tirucalli latex is classified as a severe skin and mucous membrane irritant and is a known co-carcinogen in some research contexts due to the presence of phorbol ester-related diterpenes; direct skin contact with undiluted latex can cause acute dermatitis, and ocular exposure has been documented to cause temporary or permanent vision impairment in case reports. No formal human toxicity studies, maximum tolerated dose data, or adverse event reporting from controlled trials exist for standardized extracts of this plant. Drug interaction data are entirely absent from published literature; however, given the cytotoxic in vitro activity, theoretical caution is warranted regarding concurrent use with chemotherapeutic agents, immunosuppressants, or anticoagulants. The plant is strongly contraindicated for internal use without medical supervision, and use during pregnancy and lactation must be avoided given the absence of safety data and the known toxic potential of its latex constituents.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

Euphorbia tirucalliPencil bushNaked ladyRubber hedge euphorbiaMilk bushSekelbos (Afrikaans)Petroleum plant

Frequently Asked Questions

What is Ahinkogye used for in traditional African medicine?
In Akan communities of Ghana and among South African traditional healers, Ahinkogye (Euphorbia tirucalli) is primarily applied topically to treat skin conditions including warts, eczema, and skin infections. The plant's antimicrobial and antioxidant phytochemical content, including ferulic acid and flavonoids, provides a plausible biochemical basis for these traditional uses, though no controlled human studies have validated these applications.
Is Euphorbia tirucalli safe to use on skin?
Undiluted latex from Euphorbia tirucalli is a potent vesicant and skin irritant that can cause acute chemical dermatitis, and ocular exposure has been linked to serious eye injury in documented case reports. Traditional preparations involve dilution or processing of plant material, but no standardized safe formulation has been scientifically validated, and self-application of raw plant material is strongly discouraged without expert guidance.
Does Euphorbia tirucalli have anti-cancer properties?
In vitro laboratory studies show that aqueous and methanol extracts of E. tirucalli reduce cancer cell viability to approximately 25% and 7% respectively at 200 μg/mL concentrations, and Artemia salina bioassays confirm cytotoxic activity with LC50 values as low as 1.381 μg/mL. However, these findings come exclusively from cell culture experiments and cannot be interpreted as evidence of anti-cancer efficacy in humans; no clinical trials have investigated this application.
What are the main bioactive compounds in Euphorbia tirucalli?
The principal identified bioactive compound in E. tirucalli is ferulic acid, detected as the dominant phenolic constituent by HPLC-UV analysis across multiple extract types. Supporting phytochemicals include polyphenols (up to 106.32 mg GAE/g), flavonoids (up to 450.83 μg QE/g), alkaloids, tannins, terpenoids, and lipid-class compounds such as linoleic acid, palmitic acid, and phytol identified via GC-MS analysis.
Are there any clinical trials on Ahinkogye or Euphorbia tirucalli?
No human clinical trials have been published on Euphorbia tirucalli or any standardized extract derived from it. All scientific evidence to date comes from in vitro assays including antioxidant activity tests, microbial inhibition studies, and cancer cell viability experiments conducted in laboratory settings. Until pharmacokinetic data, safety studies, and controlled human trials are completed, no evidence-based dosing or therapeutic recommendations can be made.
How does Euphorbia tirucalli compare to other antioxidant herbs in terms of free radical scavenging power?
Euphorbia tirucalli demonstrates exceptional antioxidant potency, with ABTS assay values exceeding 718.99 μM trolox/g in dry plant extracts, ranking it among the most potent botanical antioxidants tested. Its polyphenol content (up to 106.32 mg GAE/g in ethyl acetate fractions) and ferulic acid composition enable superior reactive oxygen species neutralization compared to many common antioxidant herbs. This makes it particularly notable for antioxidant supplement formulations targeting oxidative stress reduction.
Can Euphorbia tirucalli extracts be used for antimicrobial or skin health purposes?
Chloroform extracts of Euphorbia tirucalli have demonstrated antimicrobial activity against Gram-positive bacteria including Staphylococcus aureus and Bacillus subtilis, suggesting potential topical applications for bacterial skin concerns. However, given the documented skin irritation risks from latex sap exposure, any antimicrobial use must employ carefully prepared extracts rather than raw plant material. The antimicrobial potential warrants further research into safe extraction and delivery methods for therapeutic use.
Who should avoid using Ahinkogye or Euphorbia tirucalli supplements?
Pregnant women and nursing mothers should avoid Euphorbia tirucalli due to its traditional use as an abortifacient and potential toxicity to developing fetuses. Children should not be given this ingredient without specific pediatric safety data, as the plant contains irritant compounds. Individuals with latex allergies may experience cross-reactivity due to the plant's latex sap composition, and those with gastrointestinal conditions should exercise particular caution given the herb's purgative properties.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.